Synthesis and in vitro antimicrobial evaluation of 5-(1-methyl-5-nitro-2-imidazolyl)-4H-1,2,4-triazoles

Archiv der Pharmazie

Volumn 335, Issue 10, 2002, Pages 495-499

  Shafiee, Abbas ^a   Sayadi, Abolfazl ^a   Roozbahani, Marjan Hosseini ^a   Foroumadi, Alireza ^a   Kamal, Fatemeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,2,4 Triazoles; 5 Nitroimidazoles; Antimicrobial activity

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 4 ETHYL 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 4 METHYL 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 4H 1,2,4 TRIAZOLE DERIVATIVE; GENTAMICIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

BACILLUS SUBTILIS; MICROBIAL SENSITIVITY TESTS; NITROIMIDAZOLES; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036965147     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200290004     Document Type: Article

References (16)

1. A. Shafiee, N. Rastkary, A. Foroumadi, J. Heterocyclic Chem. 1998, 35, 607-610.
2. J. M. Kane, M. W. Dudley, S. A. Sorensen, F. P. Miller, J. Med. Chem. 1988, 31, 1253.
3. rd Edition. Lea & Febiger, London 1989, p. 734.
4. F. T. Boyle, European Patent Appl. 1989, E.P. 122, 693; Chem. Abstr. 1985, 102, 149273y.
5. J. M. Kane, M. A. Staeger, C. R. Dalton, F. P. Miller, M. W. Dudley, A. M. L. Ogden, J. H. Kehne, H. J. Ketteler, T. C. Mccloskey, Y. Sanyah, P. A. Chmelewski, J. A. Miller, J. Med. Chem. 1994, 37, 125.
6. J. A. Upcropt, R. W. Campbell, K. Benakli, P. Upcropt, P. Vanella, Antimicrob. Agents Chemother. 1999, 43, 73-76.
7. J. Heyes, N. Ward, Ger. Offen. 1972, 2, 142, 832, Chem. Abstr. 1972, 77, 19645a.
8. A. Foroumadi, M. Mirzaei, A. Shafiee, Farmaco 2001, 56, 621-623.
9. K. Butler, H. L. Howes, J. E. Lynch, D. K. Pirie, J. Med. Chem. 1967, 10, 891-897.
10. C. Caser, C. Drisan, R. Horclois, R. M. Jacob, J. Robert, S. Tchelitcheff, R. Vaupre, Arzneim. Forsch. 1966, 16, 23-29.
11. N. F. Eweiss, A. A. Bahajaj, E. A. Elsherbini, J. Heterocyclic Chem. 1986, 23, 1451-1458.
12. A. Jalilian, S. Sattari, M. Bineshmarvasti, A. Shafiee, M. Daneshtalab, Arch. Pharm. Med. Chem. 2000, 333, 347-354.
13. A. Shafiee, K. Parang, M. Khazan, F. Ghasemian, J. Heterocyclic Chem. 1992, 29, 1859.
14. A. Shafiee, M. Mohamadpour, F. Abtahi, A. Khoyi, J. Pharm. Sci. 1981, 70, 510-513.
15. G. Asto, J. English, U.S. 1971, 3, 565,892; Chem. Abstr. 1971, 75, 36041b.
16. th Edition, C.V. Mosby Co., Baltimore 1990, Chapter 13, pp. 173-185.